Nova Cannabis Inc.

TSX:NOVC.TO

1.75 (CAD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 69.18664.25767.38867.73264.0360.17561.38258.90756.29949.83247.62638.65529.68718.396-25.02715.97814.37215.69912.99812.929
Cost of Revenue 55.28751.26953.10850.72249.41547.31848.61947.77345.69840.47639.21732.13624.51513.609-15.9310.6279.44810.4969.5429.245
Gross Profit 13.89912.98814.2817.0114.61512.85712.76311.13410.6019.3568.4096.5195.1724.787-9.0975.3514.9245.2033.4563.684
Gross Profit Ratio 0.2010.2020.2120.2510.2280.2140.2080.1890.1880.1880.1770.1690.1740.260.3630.3350.3430.3310.2660.285
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 8.5689.6329.0337.9948.1567.9349.2877.7177.3931.9661.5421.8632.2951.8111.9720.6450.6680.6250.6250.6
Selling & Marketing Expenses 2.041.1361.8360.0270.0150.0270.0120.0120.0146.6876.8545.6775.0063.1013.0282.6432.6123.1843.4612.839
SG&A 11.93811.30110.9088.0218.1717.9619.2997.7297.4078.6538.3967.547.3014.912-6.4673.2883.283.8094.0863.439
Other Expenses 00000000000-0.2920.286-0.525000000
Operating Expenses 11.93811.30110.90812.38512.25812.35113.44211.5911.19111.28511.06210.28510.4376.455-1.434.6144.5354.9266.64.334
Operating Income 1.9611.6873.3723.3272.1850.309-3.568-0.457-0.711-2.806-4.702-5.049-6.544-1.703-8.8221.8490.3740.232-1.681-0.662
Operating Income Ratio 0.0280.0260.050.0490.0340.005-0.058-0.008-0.013-0.056-0.099-0.131-0.22-0.0930.3520.1160.0260.015-0.129-0.051
Total Other Income Expenses Net -1.102-2.02-2.934-1.319-0.1820.046-3.012-0.0150.18-0.721-1.619-1.574-0.847-0.532-3.241.114-0.013-0.416-1.92-0.43
Income Before Tax 0.859-0.3330.4382.0971.036-0.544-4.767-1.535-1.37-3.533-5.13-6.237-7.022-2.225-10.3711.373-0.091-0.184-3.601-1.092
Income Before Tax Ratio 0.012-0.0050.0060.0310.016-0.009-0.078-0.026-0.024-0.071-0.108-0.161-0.237-0.1210.4140.086-0.006-0.012-0.277-0.084
Income Tax Expense -0.92.7512.7821.2091.1391.0961.0741.0630.9730.9020.8570.9330.764-0.5-2.7580.4760.465000
Net Income 0.859-0.3330.4382.0971.036-0.544-4.767-1.535-1.37-3.533-5.13-6.237-7.022-2.225-10.3711.373-0.091-0.184-3.601-1.092
Net Income Ratio 0.012-0.0050.0060.0310.016-0.009-0.078-0.026-0.024-0.071-0.108-0.161-0.237-0.1210.4140.086-0.006-0.012-0.277-0.084
EPS 0.014-0.0060.0080.0370.018-0.01-0.083-0.027-0.024-0.062-0.09-0.11-0.12-0.058-0.290.024-0.002-0.014-0.27-0.081
EPS Diluted 0.014-0.0060.0080.0360.018-0.01-0.083-0.027-0.024-0.062-0.09-0.11-0.12-0.058-0.290.024-0.002-0.014-0.27-0.081
EBITDA 4.8374.4816.1987.4625.3263.2677.5132.2792.1040.7010.013-1.022-2.275-0.65-9.3692.0611.6420.674-1.391-0.479
EBITDA Ratio 0.070.070.0920.110.0830.0540.1220.0390.0370.0140-0.026-0.077-0.0350.3740.1290.1140.043-0.107-0.037